Skip to main content
AstraZeneca PLC logo

AstraZeneca PLC — Investor Relations & Filings

Ticker · AZN ISIN · GB0009895292 LEI · PY6ZZQWO2IZFZC3IOL08 IL Manufacturing
Open in API
Filings indexed 3,411 across all filing types
Latest filing 2022-03-23 AGM Information
Country GB United Kingdom
Listing IL AZN

About AstraZeneca PLC

https://www.astrazeneca.com/

AstraZeneca PLC is a global, science-led biopharmaceutical company that focuses on the discovery, development, and commercialization of prescription medicines. The company's portfolio is concentrated on several main therapy areas, including Oncology; Cardiovascular, Renal & Metabolism; and Respiratory & Immunology. AstraZeneca is committed to advancing healthcare through a robust research and development pipeline, aiming to deliver innovative medicines that address significant unmet medical needs for millions of patients worldwide. The company leverages scientific innovation to transform the future of healthcare and improve patient outcomes.

Recent filings

Filing Released Lang Actions
NOTICE OF AGM
AGM Information Classification · 95% confidence The document is a Form 6-K filing by AstraZeneca PLC, submitted to the SEC as a report of a foreign issuer. The content primarily consists of a Notice of Annual General Meeting (AGM) scheduled for April 29, 2022, including details about the meeting agenda, location, and shareholder voting rights. It references the Annual Report and Form 20-F Information 2021 as already published on February 22, 2022, but this document itself is the notice of the AGM, not the report. The document length is 5647 characters, which is sufficient to contain the full notice text rather than just a brief announcement. The key focus is on the AGM notice and related shareholder meeting information, which fits the definition of AGM Information (AGM-R). Therefore, the correct classification is AGM-R with high confidence.
2022-03-23 English
FORM 6-K
AGM Information Classification · 100% confidence The document is a Form 6-K filed with the SEC by AstraZeneca PLC, containing a Notice of Annual General Meeting (AGM) 2022 and Shareholders' Circular. It includes detailed information about the AGM agenda, such as receiving accounts, dividend confirmation, reappointment of auditors, election and re-election of directors, remuneration report, political donations, and allotment of new shares. The document is focused on the AGM event and related shareholder communications rather than the full annual report or financial statements themselves. The presence of proxy forms, attendance cards, and instructions for shareholder questions further confirms this is AGM-related material. Therefore, the document fits the category of AGM Information (AGM-R).
2022-03-23 English
Notice of AGM
Report Publication Announcement Classification · 99% confidence The document explicitly states 'Notice of Annual General Meeting' and details the date, time, and location of the AGM, along with the business to be conducted (resolutions 1 through 13). This directly relates to the AGM Information category. Although it mentions the publication of the Annual Report, the primary purpose of this specific filing is to announce and provide the notice for the AGM. Therefore, the most appropriate classification is AGM-R.
2022-03-23 English
Proposed Extension of Sharesave Scheme
Share Issue/Capital Change Classification · 19% confidence
2022-03-23 English
Proxy Form
AGM Information Classification · 99% confidence The document text explicitly contains the title "Attendance Card Annual General Meeting" and a detailed "Proxy Form: Annual General Meeting" for AstraZeneca PLC, scheduled for Friday, 29 April 2022. These materials (attendance cards and proxy forms) are sent to shareholders specifically to facilitate participation and voting at the Annual General Meeting (AGM). This directly corresponds to the definition of AGM Information (AGM-R). Although it contains voting instructions, the primary context is the meeting itself, making AGM-R a better fit than DVA (which is for reporting results) or PSI (which is for solicitation/information statements, though related).
2022-03-23 English
Notice of Annual General Meeting
AGM Information Classification · 100% confidence The document explicitly begins with the title "Notice of AGM" and refers to the "Annual General Meeting 2022" and the "Shareholders' Circular". It details the date, time, and location of the AGM, outlines various resolutions to be voted upon (including receiving accounts, reappointing the auditor, director elections, remuneration report approval, and share allotment authority), and includes a letter from the Chair to the shareholders regarding the meeting. This content is characteristic of the materials distributed to shareholders in advance of an Annual General Meeting. Therefore, the classification is AGM-R (AGM Information).
2022-03-23 English

Browse filings by year

34 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.